English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.

Int J Clin Oncol · 2024 · PMC11130037 · PMID 38609732

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the subgroup analyses for GIST with tumor rupture, two RCTs showed a significant survival benefit for adjuvant imatinib therapy, and the remaining one RCT showed a trend toward improving survival after adjuvant imatinib therapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.